Area of research
Oncology · Cancer Research
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, and Lung Cancer Treatments and Mutations.
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study
Transitioning single-cell genomics into the clinic
Immune Checkpoint Inhibitor-Induced Myocarditis, Myositis, Myasthenia Gravis and Transaminitis: A Case Series and Review
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies
Chemotherapy and radiotherapy for advanced pancreatic cancer
Precision Oncology in Surgery
MASTL overexpression promotes chromosome instability and metastasis in breast cancer
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
Whole-genome landscape of pancreatic neuroendocrine tumours
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
Genomic analyses identify molecular subtypes of pancreatic cancer
Hypermutation In Pancreatic Cancer
Whole genomes redefine the mutational landscape of pancreatic cancer
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities
Clinical and pathologic features of familial pancreatic cancer
Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater
Clinical and molecular characterization of HER2amplified-pancreatic cancer
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
The prognostic and predictive value of serum CA19.9 in pancreatic cancer